Birchview Capital’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,560
| Closed | -$110K | – | 69 |
|
|
2024
Q3 | $110K | Sell |
10,560
-5,000
| -32% | -$52K | 0.1% | 51 |
|
|
2024
Q2 | $306K | Sell |
15,560
-500
| -3% | -$9.84K | 0.28% | 44 |
|
|
2024
Q1 | $411K | Hold |
16,060
| – | – | 0.34% | 39 |
|
|
2023
Q4 | $443K | Sell |
16,060
-6,700
| -29% | -$185K | 0.35% | 36 |
|
|
2023
Q3 | $1.38M | Buy |
22,760
+10,300
| +83% | +$626K | 1.18% | 14 |
|
|
2023
Q2 | $820K | Buy |
12,460
+2,500
| +25% | +$165K | 0.61% | 28 |
|
|
2023
Q1 | $633K | Buy |
9,960
+5,060
| +103% | +$322K | 0.5% | 28 |
|
|
2022
Q4 | $678K | Hold |
4,900
| – | – | 0.48% | 28 |
|
|
2022
Q3 | $620K | Hold |
4,900
| – | – | 0.44% | 35 |
|
|
2022
Q2 | $406K | Buy |
4,900
+700
| +17% | +$58K | 0.3% | 41 |
|
|
2022
Q1 | $407K | Hold |
4,200
| – | – | 0.29% | 44 |
|
|
2021
Q4 | $839K | Sell |
4,200
-2,285
| -35% | -$456K | 0.54% | 32 |
|
|
2021
Q3 | $1.61M | Buy |
6,485
+772
| +14% | +$191K | 1.09% | 16 |
|
|
2021
Q2 | $2.37M | Sell |
5,713
-116
| -2% | -$48.1K | 1.42% | 12 |
|
|
2021
Q1 | $2.28M | Buy |
5,829
+1,043
| +22% | +$407K | 1.35% | 14 |
|
|
2020
Q4 | $2.68M | Buy |
4,786
+154
| +3% | +$86.3K | 1.55% | 14 |
|
|
2020
Q3 | $3.24M | Hold |
4,632
| – | – | 2.16% | 7 |
|
|
2020
Q2 | $3.66M | Buy |
+4,632
| New | +$3.66M | 2.21% | 7 |
|